Angiotensin-converting enzyme inhibitor-induced angioedema and hereditary angioedema: A comparison study of attack severity

9Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

Abstract

Objective There appears to be differences in the clinical presentation of hereditary angioedema (HAE) and angiotensin-converting enzyme inhibitor-induced (ACE-I) angioedema (AE). The aim of this study was to compare the clinical characteristics of these two AE forms. Methods We conducted a retrospective study of consecutive patients with HAE or ACE-I AE. The attack characteristics experienced by the patients were compared by a logistic regression analysis using generalized estimating equations. Results A total of 56 patients were included in this study (ACE-I AE, n=25; HAE, n=31). A total of 534 attacks were documented. Severe attacks were more common in the patients who had an acute episode of ACE-I AE than HAE. Swelling of the tongue, lips and larynx were significantly associated with ACE-I AE [OR: 8.70 (95% CI, 1.04-73.70), OR: 20.4 (95% CI, 4.9-84.2) and OR: 7.50 (95% CI, 1.20-48.30), respectively]. Conclusion Swelling of the tongue, lips and larynx are significantly more frequent in drug-induced AE than HAE.

Cite

CITATION STYLE

APA

Javaud, N., Charpentier, S., Lapostolle, F., Lekouara, H., Boubaya, M., Lenoir, G., … Fain, O. (2015). Angiotensin-converting enzyme inhibitor-induced angioedema and hereditary angioedema: A comparison study of attack severity. Internal Medicine, 54(20), 2583–2588. https://doi.org/10.2169/internalmedicine.54.4181

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free